ORMP
Oramed Pharmaceuticals Inc
Price:  
3.58 
USD
Volume:  
221,045.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP Relative Valuation

-217.2%
Upside

As of 2024-02-28, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is (4.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.58 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is -217.2%.

The range of the Relative Valuation is (2.89) - (4.60) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 7.1x - 11.4x 9.8x
Forward P/E multiples 6.7x - 13.6x 10.8x
Fair Price (2.89) - (4.60) (4.19)
Upside -180.8% - -228.6% -217.2%
3.58 USD
Stock Price
(4.19) USD
Fair Price

ORMP Relative Valuation - Historical P/E Data

Date P/E
2024-02-27 -8.83
2024-02-26 -8.76
2024-02-23 -8.54
2024-02-22 -8.14
2024-02-21 -7.92
2024-02-20 -7.77
2024-02-16 -7.75
2024-02-15 -7.75
2024-02-14 -7.72
2024-02-13 -7.48
2024-02-12 -7.82
2024-02-09 -7.03
2024-02-08 -6.64
2024-02-07 -7.01
2024-02-06 -6.98
2024-02-05 -6.46
2024-02-02 -6.79
2024-02-01 -6.98
2024-01-31 -7.39
2024-01-30 -7.35
2024-01-29 -6.37
2024-01-26 -5.72
2024-01-25 -5.60
2024-01-24 -5.60
2024-01-23 -5.65
2024-01-22 -5.44
2024-01-19 -5.49
2024-01-18 -5.40
2024-01-17 -5.38
2024-01-16 -5.63
2024-01-12 -5.77
2024-01-11 -5.72
2024-01-10 -5.65
2024-01-09 -5.97
2024-01-08 -5.97
2024-01-05 -6.09
2024-01-04 -5.90
2024-01-03 -5.85
2024-01-02 -6.04
2023-12-29 -5.70
2023-12-28 -5.77
2023-12-27 -5.48
2023-12-26 -5.33
2023-12-22 -5.87
2023-12-21 -5.77
2023-12-20 -5.40
2023-12-19 -5.55
2023-12-18 -5.38
2023-12-15 -5.43
2023-12-14 -5.82